An improved method for the detection of white spot syndrome virus (WSSV) by single-tube nested deoxyribonucleic acid amplification and a detection kit utilizing the method

MYPI1999004454A0Inactive Publication Date: 2001-04-14UNIVERSITI PUTRA MALAYSIA
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
MYPI1999004454
Authority / Receiving Office
MY · MY
Patent Type
Applications
Current Assignee / Owner
Filing Date
1999-10-14
Publication Date
2001-04-14
Estimated Expiration
Not applicable · inactive patent

AI Technical Summary

Technical Problem

Current methods for detecting White Spot Syndrome Virus (WSSV) in shrimp using PCR are limited by low sensitivity and specificity, prone to non-specific amplification, and risk of contamination, requiring multiple steps and additional reagents, which complicates accurate diagnosis and increases the chances of erroneous results.

Method used

A single-tube nested PCR method using external and internal oligonucleotide primers with specific temperature profiles and concentrations, along with internal control primers and a genetically modified positive control, to enhance sensitivity and specificity while reducing background amplification and contamination risks, allowing for accurate detection and semi-quantitative analysis in a single reaction vessel.

Benefits of technology

This approach simplifies the detection process, increases specificity and sensitivity, reduces the risk of contamination, and provides accurate, reliable results with enhanced sensitivity and specificity, enabling effective diagnosis and semi-quantitative analysis of WSSV infections in a single reaction tube, improving the accuracy and reliability of WSSV PCR diagnosis.

✦ Generated by Eureka AI based on patent content.
Patent Text Reader
Need to check novelty before this filing date? Find Prior Art

Description

ABSTRACTThe method of detection employs a nucleic acid amplification process using PCR by first 10 amplifying an outer WSSV genomic DNA fragment that may be present in extracted DNA of clinical specimen using an ‘external’ set of two oligonucleotide primers. Sensitivity and specificity are then increased through a second round of nucleic acid amplification of an internal WSSV DNA segment located within the amplified outer WSSV genomic DNA fragment using an ‘internal’ set of two oligonucleotide primers. The amplification process with these nested primers also reduces background and non-specific amplification. A detection kit the above incorporating the above is disclosed.Figure 1AN IMPROVED METHOD FOR THE DETECTION OF WHITE SPOT SYNDROME VIRUS (WSSV) BY SINGLE -TUBE NESTEDDEOXYRIBONUCLEIC ACID AMPLIFICATION AND A DETECTION KIT UTILIZING THE METHODFIELD OF THE INVENTIONThe present invention relates to an improved method to detect White Spot Syndrome Virus (WSSV) by nucleic acid amplification utilizing the to Polymerase Chain Reaction (PCR) technology. More particularly the invention relates to methods involving a single-tube-nested amplification of WSSV nucleic acid in clinical specimen with verification using novel control standards. In another aspect the invention relates to a kit utilizing the method. The kit offers a simplified nested PCR assay with enhanced target specificity and sensitivity over prior methods in WSSV detection.BACKGROUND OF THE INVENTIONWhite Spot Syndrome Virus (WSSV) is a serious pathogen of wild and cultured penaeid shrimp. It has been associated with a syndrome with high mortalities since 1993 in cultured shrimp from Asia and the Indo-pacific. Although the virus has been related to the Baculoviridae family group of viruses and to the subfamily of the non-occluded baculovirus; the Nudibaculoviridae, present taxonomical position of the virus is still left unassigned. Four different names have been reported for the virus:Baculoviral Hypordermal and Haematopoietic Necrosis Virus (HHNBV) by Huang et al. (1994), Rod-shaped Virus of Penaeus japonicus (RV-PJ) by Inouye et al. (1994), Systemic Ectodermal and Mesodermal baculovirus (SEMBV) by Wongteerasupaya et al. (1995) and White Spot Baculovirus (WSBV) by Wang et al. (1995). Recently, White Spot Syndrome Virus (WSSV) has been adopted to represent the venacular name of the virus.Infections are normally accompanied by the presence of white spots on the exoskeleton and epidermis of diseased shrimp. Other clinical signs include lethargy and anorexia. The target tissues are generally of mesodermal and ectodermal origin including connective and epithelial tissues (Durand et al., 1996). Infection spreads rapidly and may accumulate in massive mortalities of the cultured shrimp within two to three days.No vaccines or disease treatment are available yet for the infection. At 5 such, considerable importance is placed on prevention strategy. Effective prevention policies will require accurate diagnosis regiment. Diagnosis of WSSV were previously done through clinical signs and histopathological examination of moribund animals (Lightner, 1996). This is however difficult and not sensitive. Recently, the application of molecular biology in the study of WSSV has provided the platform for the use of rapid molecular diagnostic probes in the detection of WSSV. Development of gene probes and its application in the diagnosis of WSSV have been reported (Durand et al., 1996). More recently, the application of enzymatic amplification of nucleic acid by the Polymerase Chain Reaction (PCR) has been applied. Use of PCR has allowed the increase in specificity and sensitivity in the detection of WSSV.PCR is a process for amplifying nucleic acids by involving the use of two oligonucleotide primers, an agent for polymerization, a target nucleic acid template, and successive cycles of thermal denaturation of nucleic acid and annealing and extension of the primers to produce a large number of copies of a particular nucleic acid segment. With this approach, a target nucleic acid segment can be amplified more than 10 million folds with very high specificity and fidelity. Detection sensitivity however is limited to the amount of amplified product available to be detected. This is particularly so if the amount of the template or target nucleic acid sequence to be amplified is low. Detection is further complicated in this case by the fact that a high ratio of non-target to target sequence occurs. PCR discrimination between non-target and target sequences is thus crucial. The reliable discrimination is at such a key aspect of improved sensitivity and relates to the specificity of the primers and the condition of the reaction conditions. The need for improved specificity and sensitivity has led to the application of a two step PCR reaction whereby the first step amplifies the target sequence and followed by a second PCR step that amplifies a sub-segment of the original target sequence amplified using another set of internal flanking oligonucleotide primers. This method increases specific amplification by reducing non-specific background amplification products and therefore increasing sensitivity. Non-specific amplified products although arise by priming of non-homology sequences will have no sufficient homology to the nested primers to allow non-specific amplification to continue. However, the two step reaction has several drawbacks resulting from the presence of the first primer pair in the second PCR, which has to be diluted for proper reaction condition. The method also requires additional reagents which includes polymerization agents or amplification enzyme. The technique is also prone to erroneous cross contamination between samples during dilution, transfer and other means of preparation. The high sensitivity of PCR can efficiently amplify small amount of amplified DNA carryover from samples with high DNA levels, positive control templates or targets from previous amplification. This will result in a PCR reaction independent of whether intentional target templates are being added.Development of PCR assay for WSSV detection has been reported byLo et al. (1996), Takahashi et al. (1996) and Kanchanaphum et al (1998). Regions of WSSV genomic DNA are utilized for the amplification process. The use of single step or two steps PCR has been employed in these studies. Use of two steps or nested PCR has been greatly emphasized in the diagnosis of WSSV as the method greatly increases specificity and sensitivity of WSSV detection. As mentioned above, the use of a two steps or nested PCR reaction in separate assays will face similar drawbacks. The possibility for error in the assay challenges the validity of diagnostic results, which is critical in the management of the disease. Realizing the disparity that can occur in; diagnostic assays involving conventional two step PCR method, we invented methods to simplify without compromising the specificity and sensitivity of a nested PCR reaction in the detection of WSSV.The need for improved methods of detecting WSSV that is easier to perform while maintaining specificity and sensitivity has been met by this present invention. Accuracy of result interpretation is also high in level due to the availability of indicators provided in the kit system.SUMMARY AND OBJECTS OF THE INVENTIONThe present invention is directed to oligonucleotide primers or probes that can be used to accurately detect the presence of WSSV in clinical 5 specimens by means of viral nucleic acid amplification using PCR. The invention is also associated with establishment of a novel reaction mix composition that provides an array of functions apart from just the detection ofWSSV, which enhances the accuracy and reliability of a WSSV PCR diagnosis on any clinical specimen. The invention is also directed to the use of novel control standards that when used in conjunction with other components of the detection assay provides the highest level of accuracy, confidence and quality control in each assay interpretation and is superior to any methods in WSSV detection.One object of the present invention is to provide oligonucleotide primers that can be used to perform a nested PCR reaction on WSSV in one reaction run with one reaction vessel, whichis far simpler to accomplish without compromising the specificity and sensitivity of a conventional two step nested PCR system.In another aspect, the invention also provides methods to more accurately diagnose WSSV infections by knowing the level or degree of infection and the accuracy of result interpretation in the presence or absence of WSSV in clinical samples. The present invention also includes a system that will provide the calibration of PCR WSSV detection sensitivity and can be adapted to locate sources of contamination in the system when it occurs.The invention discloses an improvement to a method to detect the presence or absence of White Spot Syndrome Virus (WSSV) target nucleic acid in shrimp or other crustacean specimen suspected of infection involving lysing WSSV particles if present and extracting nucleic acid molecules therefrom and one reaction mix comprising an outer and inner oligonucleotide primer probe for single step and nested WSSV target nucleic acid amplification within one nucleic acid amplification reaction. The improved method comprises the steps of: 5a) contacting the nucleic acid molecules with outer oligonucleotide primer probes;b) enzymatically amplifying a specific region of nucleic acid molecules;c) contacting the amplified nucleic acid molecules if present from step (b) with inner oligonucleotides primer probes; andd) enzymatically amplifying a specific region of nucleic acid molecule comprising the target sequences of WSSV in a subsequent nucleic acid amplification using inner oligonucleotide primer probes.Lysing WSSV particles, if present and extracting nucleic acid is by using guanidine isothiocyanate containing lysis buffer. The nucleic acid molecules is contacted with outer oligonucleotides under conditions to permit hybridization by first denaturing the nucleic acid molecules at a temperature of about 85°C to 95°C and then annealing the probes kept at low concentration to the denatured nucleic acid molecules, at a temperature of 60°C to 65°C. Enzymatically amplifying a specific region of nucleic acid comprises a first stage or phase of nucleic acid amplification of the target sequences of WSSV using outer primer oligonucleotide probes.The contacting of the amplified nucleic acid molecules, if present from the first stage of nucleic acid amplification with inner oligonucleotides primer probes is executed under condition to permit the hybridization by first denaturing the nucleic acid molecules at a temperature of about 85°C to 95°C and then annealing the probes kept at high concentration to the denatured nucleic acid molecules at a temperature of 45°C to 50°C.The method of detection is enhanced by using outer and inner oligonucleotide primer probes in the reaction mix at determined concentrations in relation with other essential reagents for PCR process.The present method of detection includes incorporation of a set of internal oligonucleotide control primers that simultaneously co-amplifies a host gene sequence independently to be used as an internal control indicator to evaluate the quality of the target template used and to confirm the proper working of the PCR process.The method further includes a positive control template to establish PCR sensitivity levels but altered genetically from a wild target sequence for easy identification and discrimination to determine whether PCR contamination has occurred and if so the source of the contamination.The outer oligonucleotide primer probes are ID1 and ID2 identified as CGTGCAAGAACTACGCCAGGTG at 70.8°C andGCTGCAGTTGAAACCCAGCGAA at 72.3’C respectively. The inner oligonucleotide primer probes are ID3 and ID4 identified as GTGCAAGAACTACGCCAG at 59.6*C and TCCCCAGGAGAAAAACTA at 57. Tc respectively. The set of internal oligonucleotide control primer probes are ID5 and ID6 identified as TGTTGCGGTTGAAACGCT at 65.5*C and CGAGGTCCTGTTCCATCATT at 63.8*C respectively.The invention discloses a kit for detecting the presence or absence ofWhite Spot Syndrome Virus (WSSV) target nucleic acid in shrimp or other crustacean specimen suspected of infection characterized in that the detection kit incorporates the steps described above in the method.DETAILED DESCRIPTION OF THE INVENTIONThe detection method of the present invention is directed to the detection of WSSV in a clinical specimen. The term clinical specimen here refers to live or shrimp tissues or juveniles (post larva) preserved in alcohol. The detection technique employs a nucleic acid amplification process usingPCR by first amplifying an outer WSSV genomic DNA fragment that may be present in extracted DNA of clinical specimen using an external set of two oligonucleotide primers. Sensitivity and specificity are then increased through a second round of nucleic acid amplification of an internal WSSV DNA segment located within the amplified outer WSSV genomic DNA fragment using an internal set of two oligonucleotide primers. The amplification process with these nested primers also reduces background and nonspecific amplification.In each of the two stages of PCR amplification, the oligonucleotide primers are allowed to hybridize to opposite strands of target DNA wherein the region specified by the two primers is copied specifically by a thermostable DNA polymerase through the elevation of temperature. The process is repeated wherein the amount of the copied DNA segment representing the region between the two primers is doubled at every cycle and the specific amplification of the targeted WSSV sequences, if present, results. In the present invention, the external and internal primer sets are all present in the initial reaction mix. The external primer can operate under high · and low temperature range, whereas the internal primer set can only function under low temperature range. These biochemical properties hence allows specific reaction function to be directed using temperature difference manipulation programmed in a thermocycler wherein the external primers are allowed at high temperature, .but not the internal primers, to amplify initially. After the first round of amplification, the second round or nested amplification step is followed upon again using temperature manipulation to allow this time at a lower temperature for both the internal and external primers to amplify.Since initial amplification was performed initially using high thermocycles, nonspecific amplification was considerably reduced without the need to perform a hotstart PCR. As the manipulation of temperature differences for the different stages of amplification can be precisely programmed in a thermocycler and the specific biochemical properties of the primers selected strictly to function only a their temperature range, both first and nested step amplification process can thus be performed automatically in one reaction tube. The correct desired result and sensitivity was achieved using a very low external primer concentration in combination with a high internal primer concentration. The combination of different primer concentrations between the external and internal primer sets was further carefully titrated to give rise to another embodiment of the present invention that is the semi-quantitative detection property. In another embodiment of the present invention, another set of primer is included in the initial reaction mix that targets a conserve crustacean gene sequence. This embodiment thus allows amplification of host DNA sequence independent of whether WSSV DNA is present or absent. The biochemical properties of the primers allow them to function at high and low thermocycle profiles. This embodiment as such serves as an internal control or false negative control for the overall PCR process that describe if the assay was correctly performed or inhibited. Again, the process occurs within the same reaction run in the same reaction tube.Further identification of the amplified products as being derived from WSSV and whether PCR was successfully performed by processing the amplified sample through agarose gel electrophoresis. Observation ofamplified bands having the correct sizes as observed after ethidium bromide staining of the gel and ultra violet illumination provides the final confirmation of detection and assay viability.Sensitivity of amplification is confirmed by subjecting known amount of WSSV DNA targets cloned in a plasmid vector in the amplification run. The WSSV DNA target is mutated to allow easy differention between wild amplified fragment and control-amplified fragment for false positive elimination and contamination trouble shooting. As the size of the wild and artificial DNA targets is identical, the amplification sensitivity is not compromised.DETAIL EXAMPLE OF APPLICATIONa) WSSV DNA ExtractionViral DNA material for use in the present invention may be extracted using guanidine isothiocyanate lysis method. This extraction method is favoured as it is simple, efficient, fast and is nontoxic in nature. Using this approach, we have found that no boiling step is required, further reducing chances of sporadic contamination from contaminated water baths, ovens etc. Considerable amount of DNA may be obtained by just allowing passive lysis of tissue in the lysis solution. In the preparation of DNA material, about 50 to 100mg of shrimp tissue of 25 to 50 pieces (50-150mg) of juvenile shrimps or post larvae, minced with sterile scalpel blades is incubated with 1 ml of guanidine thiocynate lysis buffer (commercially available as DNAzol™, Molecular Research, USA) for 15 to 30 minutes. Lysed samples are then centrifuged at 10,000 x g for 10 minutes. The resulting supernatant is then transferred to a fresh tube and 0.5 ml of 100% ethanol is added to precipitate the DNA. Precipitated DNA is pelleted down at 5,000 x g for 5 minutes. Discard supernatant and wash DNA pellet thrice with 1 ml of 95% ethanol. Supernatant is discarded after each wash by pelleting DNA with the first two wash performed at 1,000 x g for 2 minutes and the final 1,000 x g for 5 minutes. Air dry DNA pellet for 2-3 minutes before solubilizing DNA pellet in 150-200μΙ of sterile distilled water.b) Nucleic Acid Amplification MethodAn aliquot of the extracted sample DNA (1-2μΙ) may be amplified using the present invention through PCR. DNA to be amplified is loaded into a sterile thin wall reaction tube that contains 62.5 nmol each of dATP, dCTP, dGTP, dTTP, 2% dimethysulfoxide (DMSO), 0.235 nmol each of the external primer set (SEQ. ID 1 and 2), 20 nmol each ofthe internal primer set (SEQ. ID 3 and 4), 2 nmol each of internal control primer set (SEQ. ID 5 and 6), 0.8 units of Tth polymerase in 1 x PCR buffer (7.5 mM Tris-HCL pH 9.0, 5 mM KCL, 2mM (NH4)2SO4, 5 mM MgCI2) with a total reaction volume of 25μΙ. Functionality of the various primer sets are governed by their different melting temperatures (Tm). The external primers have a Tm of around 71 °C whereas the internal primers have a Tm of around 60’C. Internal control primers have a Tm of 65°C. These differences allows the manipulation of thermodynamic profiles of the PCR process by which in the first stage of PCR amplification, only external primers can function while internal primers will not be able to hybridize or anneal to template DNA. At the second stage or nested of amplification, the thermocycling temperature is lowered to allow both external and internal primers to participate in amplification. These parameters are thus programmed and performed in a thermocycler with the amplification cyclesconsisting of: Pre-denaturation 94*C - 3 minutes 5 cycles 94°C - 30 seconds 60’C - 30 seconds 72*C - 30 seconds 15 cycles 94°C - 25 seconds (First stage PCR amplification) 60’C - 25 seconds 72*C - 30 seconds 6 cycles 94*C - 25 seconds (Second stage or nested PCR amplification) 50*C - 25 seconds 72*C - 25 seconds 25 cycles 94*C - 25 seconds (Second stage or nested PCR amplification) 49*C - 25 seconds 72°C - 25 secondsAnd a final extension step at 72°C for 3 minutes.c) Detection of Amplified Nucleic Acid FragmentsAmplified nucleic acids are visualized by analyzing 10μΙ of PCR products in 2% agarose gel electrophoresis in TBE (89 mM Tris-borate, 2 mM EDTA, pH8.2) containing ethidium bromide under UV illumination. The specifically amplified regions are confirmed using DNA size markers whereby presence of WSSV will result in either a 356-bp or both 356-bp and 403-bp fragments (Figure II) depending on the severity of infection. An internal control fragment having a size of 232-bp, an amplified region of the host decapod gene will also be present indicating the PCR process was successfully performed, eliminating the possibility of false negative result interpretation.d) Semi-quantification of Infection LevelInfection level may be semi-quantified by visualizing the number and intensity of PCR WSSV bands present after electrophoresis analysis. Results can be compared to quantified standard controls involving linearized plasmids having cloned WSSV target DNA amplified using the same method (Figure II).The semi-quantitative property of the present invention provides an indicator of the severity or degree of infection in clinical specimen tested.e) Development and Construction of Mutant Plasmid ControlPositive control used for the verification of sensitivity and level of infection was further developed and constructed to allow a rapid and easy differentiation between amplified wild type and artificial positive control fragment This was accomplished using single base mutagenesis to introduce a unique Xba I restriction site into wild type sequence. Single base mutagenesis of the wild type fragment was constructed at position 469 of a conserve WSSV genomic region as reported by Takahashi et al. (1996), where a single nucleic acid base; cytosine was replaced with thymidine using the megaprimer PCR approach. The mutant WSSV target was first generated by first amplifying a 85 bp fragment using oligonucleotide primer Seq. ID No. 1 and a specially design mutagenic oligonucleotide primer Seq. ID No.7 usingPCR. This fragment or megaprimer was then excised from gel, purified using a commercial gel purification kit and used to generate the complete 402 bp WSSV target by reamplification with oligonucleotide primer Seq. ID No.2 in the presence of complete wild type target fragment. Construction of the mutant plasmid was done using 100 nmol each of dNTPs, 25 nmol of primerSeq. ID No.1 and Seq. ID No.7 in 1 x PCR buffer (10 nM Tris-HCI, pH 8.3, 50 mM KCI, 1.5 mM MgCb) with 2 units of AmpliTaq GoldTfnin a total reaction volume of 50μΙ in a hotstart PCR process. PCR was performed using an initial .12 denaturation of 95°C for 10 minutes, followed with 15 cycles of 94’C for 2 minutes, 50’C for 2 minutes, 75*C for 2 minutes and a final extension at 75’C for 5 minutes. Primer Seq. ID No. 2 at a concentration of 50 nmol was then added into the reaction tube and another 15 cycles of thermocycling using the same cycling profile was performed. The mutant WSSV fragment generated was then electrophoressed, excised, purified and cloned into a commercial plasmid vector.Amplified mutant WSSV DNA target containing the unique restriction site may be differentiated against the wild type fragment by treating 10 μΙ ofPCR products with Xba I restriction enzyme for 1 hour at 37*C. PCR fragment containing amplified wild type sequence will not be enzyme restricted or cut (remain at 402-bp) while mutant PCR fragment having the Xba I restriction site will be digested to form two subfragments, i.e. 327 and 75 bp segments (Figure II).A kit for detection the presence or absence of White Spot SyndromeVirus (WSSV) target nucleic acid in shrimp tissues or other crustacean infected specimen utilizing the steps b, c, d and e described above is used.TABLE 1Oligonucleotide sequenceExternal Primers:Seq. ID No.1: CGTGCAAGAACTACGCCAGGTG Seq. ID No.2: GCTGCAGTTGAAACCCAGCGAAInternal Primers:Seq. ID No.3: GTGCAAGAACTACGCCAG Seq. ID No.4: TCCCCAGGAGAAAAACTATm70.8’C72.3’C59.6C 57.1 °CInternal Control Primers:Seq. ID No.5: TGTTGCGGTTGAAACGCT Seq. ID No.6: CGAGGTCCTGTTCCATCATT65.5’C63.8’CMutagenic Primer:Seq. ID No.7: TTCTTGTCTAAATATTCCTTCTTC 50*CThis methods comprises a set of novel, user friendly approaches for nested PCR reaction and counter verification with engineered control indicators packed in a kit format. Using this invention, the first step and nested PCR steps are performed within one reaction run in one reaction vessel or tubes as oppose to conventional methods that requires two separate reactions in two reaction tubes (Figure 1). This method thus provides simplicity, a faster assay, and a more economical approach in the screening of infected specimen. The decrease in manipulative steps involved in the preparation of a nested PCR assay also greatly reduces and minimizes the opportunity for cross contamination and subsequent inaccurate results.As an embodiment of the present invention, the detection system has also a semi quantitative detection result through the use of novel reaction mix composition of the primer probes concentration in relation to other reagents required for the PCR process to proceed. Quantification is made possible as the composition provides indicators of the level of infection between severe infection and light infection by simple visualization of the appearance and number of bands corresponding to the infection status. The composition developed is also sensitive enough to detect the extreme spectrum of one copy target sequence.Another embodiment of the present invention is incorporation of oligonucleotide probes that act as a false negative control in the reaction mix composition by co-amplifying a host gene sequence to determine the quality of the extracted DNA used as target template for each individual clinical specimen. The embodiment performs independently regardless of whetherWSSV genomic DNA is present or absence. This will allow a more accurate reading of diagnostic results as negative samples will still produce a PCR band of a distinct size to indicate the quality of DNA and proper working of the PCR reaction.In another embodiment of the present invention, a genetically engineered positive control target sequence fragment was invented for use as a PCR sensitivity control. The invention is novel as it can be used to determine the source of the contamination if and when it occurs by discriminating between wild type (natural) contamination from amplified DNA carryover from infected specimen and positive control contamination derived from the kit. A subtle nucleic acid base change in the engineered control allows the fragment to stay uncut as compared to the wild type amplified fragment after treatment with a restriction enzyme. This property provides a method to differentiate between wild or kit positive control fragment by visual observing the size of the PCR products after gel electrophoresis and staining.REFERENCESHuang, J., Song, X.L., Yu, J., Yang, C.H. (1994) Baculoviral hypodermal and hematopoeitic necrosis-pathology of the shrimp explosive epidemic disease. Yellow Sea Fishery Research Institute, Qingdao, PR, China (abstract).Inouye, K., Miwa, S., Oseko, N., Nakano, H., Kimura, T., Momoyama, K., Hiraoka, M., (1994) Mass Mortalities of cultured Kuruma shrimp Penaeus japonicus in Japan in 1993: electron microscopic evidence of the causative virus. Fish Pathology 29: 149-158.Wongteerasupaya, C., Vickers, J.E., Sriurairatana, S., Nash, G.L., Akarajamorn, A., Boosaeng, V., Panyim, S., Tassanakajon, A., Withyachumnarnkul, B., Flegel, T.W. (1995) A non-occluded, systemic baculovirus that occurs in cells of ectodermal and mesodermal origin and causes high mortality in the black tiger prawn Penaeus monodon. Diseases of Aquatic Organisms 21:69-77.Wang, C.H., Lo, C.F., Leu, J.H., Chou, C.M., Yeh, P.Y., Chou, H.Y., Tung, M.C., Chang, C.F., Su, M.S., Kou, G.H. (1995) Purification and genomic analysis of baculovirus associated with white spot syndrome (WSBV) of Penaeus monodon. Diseases of Aquatic Organisms 23:239-242.Durand, S., Lightner, D.V., Nunan, L.M., Redman, R.M., Mari, J., Bonami, J.R. (1996) Application of gene probes as diagnostic tools for White Spot Baculovirus (WSBV) of penaeid shrimp. Diseases of Aquatic Organisms 27:59-66.Lightner, D.V., (1996) Handbook of shrimp pathology and diagnostic procedures for diseases of cultured penaeid shrimp. World AquacultureSociety, Baton Rouge, Louisiana.Lo, C.F., Leu, J.H., Ho, C.H., Chen, C.H., Peng, S.E., Chen, Y.T., Chou, C.M., Yeh, P.Y., Huang, C.J., Chou, H.Y., Wang, C.H., Kou, G.H. (1996) Detection of baculovirus associated with white spot syndrome (WSBV) in penaeid shrimp using polymerase chain reaction. Diseases of Aquatic Organisms25:133-141.Takahashi, Y., Itami, T., Maeda, M., Suzuki, N., Kasornchandra, J., Supamattaya, K., Khongpradit, R., Boonyaratpalin, S., Kondo, M., Kawai, K., Kusuda, R., Hirono, I., Aoki, T. (1996) Polymerase chain reaction (PCR) amplification of baciliform virus (RV-PJ) DNA in Penaeus japonicus Bate and systemic ectodermal and mesodermal virus (SEMBV) DNA in Penaeus monodon Fabricus. Journal of Fish Diseases 19:399-403.Kanchanaphum, P., Wongteerasupaya, C., Sitidilokratana, N., Boonsaeng, V.,Panyim, S., Tassanakajon, A., Withyachumnarnkul, B., Flegel, T.W. (1998) Experimental transmission of White Spot Syndrome Virus from crabs to shrimp Penaeus monodon. Diseases of Aquatic Organisms 34:1-7.

Claims

CLAIMS 1. Improvement to a method to detect the presence or absence of White Spot Syndrome Virus 5 (WSSV) target nucleic acid in shrimp or other crustacean specimen suspected of infection, involving lysing WSSV particles if present and extracting nucleic acid molecular therefrom and one reaction mix comprising an outer and inner oligonucleotide primer probe for single step and nested WSSV target nucleic acid amplification within one nucleic acid amplification reaction, wherein the improved method comprises the steps of :10 a) contacting the nucleic acid molecules with outer oligonucleotide primer probes; b) enzymatically amplifying a specific region of nucleic acid molecules; c) contacting the amplified nucleic acid molecules if present from step (b) with inner oligonucleotide primer probes; and 15 d) enzymatically amplifying a specific region of nucleic acid molecule comprising the target sequences of WSSV in a subsequent nucleic acid amplification using inner oligonucleotide primer probes.2.1mprovement to a method to detect the presence or absence of White Spot Syndrome Virus 20 (WSSV) in shrimp or other crustacean specimen suspected of infection and wherein the improved method comprises the steps of :a) preparing one reaction mix comprising an outer and inner oligonucleotide primer probes for single step and nested WSSV target nucleic and amplification within one nucleic acid 25 amplification reaction. b) contacting the nucleic acid molecules with oligonucleotides primer probes; c) enzymatically amplifying a specific region of nucleic acid molecules; d) contacting the amplified nucleic acid molecules from step (c) with inner oligonucleotides primer probes; e) enzymatically amplifying a specific region of nucleic acid molecule comprising the target sequences of WSSV in a subsequent nucleic acid amplification using inner oligonucleotide primer probes.

53. The improvement to a method as claimed in claim 1, where lysing WSSV particles by using guanidine isothiocyanate containing lysing buffer.

4. The improvement to a method as claimed in Claim 1 or 2 wherein contacting the nucleic acid molecules, if present with outer oligonuctides primer probes is executed under conditions 10 to permit hybrization by first denaturing then nucleic acid molecules at a temperature of about 85 °C to 95 °C and then annealing the probes kept at low concentration to the denatured nucleic acid molecules at a temperature of 60°C to 65°C.

5. The improvement to a method as claimed in Claims 1 or 2 wherein enzymatically 15 amplifying a specific region of nucleic acid comprises a first stage or phase of nucleic acid amplification of the target sequences of WSSV in using outer oligonucleotides primer probes.

6. The improvement to a method as claimed in Claims 1 or 2 wherein contacting the amplified nucleic acid molecules, if present from the first stage of nucleic acid amplification with inner 20 oligonucleotides primer probes is executed under condition to permit the hybridization by first denaturing the nucleic acid molecules at a temperature of about 85°C to 95°C and then annealing the probes kept at high concentration to the denatured nucleic acid molecules at a temperature of 45 °C to 50°C.

257. The improvement to a method as claimed in Claims 1 or 2 wherein the method of detection is enhanced by using outer and inner oligonucleotide primer probes in the reaction mix at determined concentrations in relation with other essential reagents for PCR process.

8. A method to detect the presence or absence of WSSV target nucleic acid in shrimp or other crustacean specimen suspected of infection as claimed in Claim 7 wherein the quantification or severity of infection in a sample of shrimp tissues or other crustacean is determined.

59. A method to detect the presence or absence of WSSV target nucleic acid in shrimp or other crustacean specimen suspected of infection as claimed in Claim 7 wherein the method of detection includes incorporation of a set of internal oligonucleotide control primers that simultaneously co-amplifiers a host gene sequence independently to be used as an internal control indicator to evaluate the quality of the target template used and to confirm the proper10 working of the PCR process. 10.A method for the detection of the presence or absence of White Spot Syndrome Virus (WSSV) target nucleic acid in shrimp or other crustacean specimen suspected of infection involving one reaction mix comprising an outer and inner primer probe for single step and 15 nested WSSV target nucleic acid amplification within one nucleic acid amplification reaction wherein the method includes a positive control template to establish PCR sensitively levels but altered generically from a wild target sequence for easy identification and discrimination to determine whether PCR contamination. 2011. A method to detect the presence or absence of WSSV target acid in shrimp or other crustacean specimen suspected of infection as claimed in Claim 1 wherein the outer oligonucleotide primer probes are IDI and ID2 identified as CGTGCAAGAACTACGCCAGTG at 70.8°C and GCTGCAGTTGAAACCCAGCGAA at 72.3°C respectively.12.A Method to detect the presence or absence of WSSV target nucleic acid in shrimp or other crustacean specimen suspected of infection as claimed in Claim 1 wherein the inner oligonucleotide primer probes are ID3 and ID4 identified as GTGCAAGAACTACGCCAG at 59.6°C and TCCCCAGGAGAAAAACTA at 57.1 °C respectively.

13. The method as claimed in claim 1, wherein the set of internal oligonucleotide control primer probes are ID5 and ID6 identified as TGTTGCGGTTGAAACGT at 65.5°C ad CGAGGTCCTGTTCCATCATT at 63.8°C respectively.

14. A kit detecting the presence or absence of White Spot Syndrome Virus (WSSV) target nucleic acid in shrimp or other crustacean specimen suspected characterized in that the detection kit incorporates the steps (a), (b),(c) and (d) of Claim 1.

15. The kit as claimed in claim 14, characterized in that the detection kit incorporates the steps (a),(b),(c) and (d) of claim 1 and steps in claim 2 to 6.

16. The kit as claimed in claim 14 comprises an automated single tube nested PCR.